Clifford Chance, Freshfields and Kirkland lead on €5.3bn Bain-Cinven pharma acquisition
Stada, maker of generic versions of drugs such as Viagra, set for private equity takeover
April 10, 2017 at 10:06 AM
2 minute read
Freshfields Bruckhaus Deringer, Clifford Chance (CC) and Kirkland & Ellis are advising on the sale of German pharmaceutical company Stada for €5.3bn (£4.5bn).
Stada, which makes various generic versions of drugs such as Viagra, agreed to support an improved joint takeover bid by private equity firms Bain Capital and Cinven today (10 April).
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 2The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
